-
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery
americanpharmaceuticalreview
January 13, 2020
Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
-
Evotec and Bayer to develop polycystic ovary syndrome drug candidates
pharmaceutical-technology
January 13, 2020
German firms Evotec and Bayer have agreed to expand their alliance to develop drug candidates for polycystic ovary syndrome (PCOS).PCOS is an endocrine disorder associated with metabolic dysfunction that can cause pregnancy complications and infertility.
-
Bayer and Azitra Partner to Harness the Human Skin Microbiome as a Source for New Natural Skin Care Products for Sensitive and Eczema-Prone Skin
firstwordpharma
January 11, 2020
Bayer and Azitra Inc., a clinical-stage medical dermatology biotech company, today announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria.
-
New set-up for IT at Bayer
worldpharmanews
December 17, 2019
Bayer is transforming its IT function to further accelerate the digitalization of the company. Leading IT providers will take over standardized services ...
-
FTC pumps the brakes on Bayer's Elanco animal health deal
fiercepharma
December 12, 2019
Bayer’s eager to send its animal health unit to Elanco so it can focus its healthcare efforts on pharmaceuticals. But that $7.6 billion sellof ...
-
Gowan Company Announces Acquisition of Two New Active Ingredients, Fenamidone and Pencycuron, from Bayer AG
En-CPhI.CN
December 03, 2019
Gowan Crop Protection Limited, an affiliate of Gowan Company, L.L.C., announced that it has entered into agreements with Bayer AG to acquire rights to the active ingredients ...
-
Bayer G4A Partners With Wellthy Therapeutics
En-CPhI.CN
October 12, 2019
Wellthy Therapeutics, South Asia's leading digital therapeutics (DTx) company today announced its partnership with Bayer through its G4A partnership initiative.
-
Bayer and RIKEN establish partnership for novel drug discovery
biospectrumasia
October 09, 2019
100 years of history, RIKEN is Japan’s largest national research organization with over 3,500 employees across 10 research sites including Kobe, Osaka, Tokyo, Harima, Yokohama and Wako.
-
Novo's Rybelsus, check. Here are the major launches coming up next
fiercepharma
September 26, 2019
The drug drew the interest of Bristol-Myers Squibb, which is set to swallow Celgene in a megamerger. Luspatercept represents a "high value near-term asset," BMS has said.
-
Bayer invests in joint research lab for chronic lung diseases
pharmaceutical-technology
September 26, 2019
Bayer has committed more than $30m over the next five years to support research projects on therapies for chronic lung diseases at a joint lab in the US.